title: A phase III randomized equivalence study of biosimilar filgrastim versus Amgen filgrastim in patients receiving myelosuppressive chemotherapy for breast cancer.
authors.affiliation: Abt. Innere Medizin I, Medizinische Universitatsklinik, Freiburg, Germany. cornelius.waller@uniklinik-freiburg.de
authors.forename: Cornelius F
authors.initials: CF
authors.lastname: Waller
authors.forename: Vladimir F
authors.initials: VF
authors.lastname: Semiglazov
authors.forename: Sergei
authors.initials: S
authors.lastname: Tjulandin
authors.forename: Dmitry
authors.initials: D
authors.lastname: Bentsion
authors.forename: Stephen
authors.initials: S
authors.lastname: Chan
authors.forename: Rodeina
authors.initials: R
authors.lastname: Challand